- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Current Treatment Options in Oncology ; 22 (2021). - Art.-Nr. 106. - ISSN 1527-2729. - eISSN 1534-6277
- Schlagwort
-
Bauchspeicheldrüsenkrebs
Metastase
Chemotherapie
- Ereignis
-
Veröffentlichung
- (wo)
-
Ulm
- (wer)
-
Universität Ulm
- (wann)
-
2021
- Urheber
- DOI
-
10.18725/OPARU-49743
- URN
-
urn:nbn:de:bsz:289-oparu-49819-0
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:46 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ettrich, Thomas J.
- Seufferlein, Thomas
- Universität Ulm
Entstanden
- 2021
Ähnliche Objekte (12)
New Advances in the Treatment of Metastatic Pancreatic Cancer
Targeting lAPs in pancreatic cancer therapy
The discovery of genes that exhibit strong effects on metastatic pancreatic cancer
Pancreatic cancer
Pancreatic cancer
Macrophages direct cancer cells through a LOXL2-mediated metastatic cascade in pancreatic ductal adenocarcinoma
Risk Evaluation of EMT and Inflammation in Metastatic Pancreatic Cancer Cells Following Plasma Treatment
Clinical application of liquid biopsy in targeted therapy of metastatic colorectal cancer
Implementing remote patient monitoring for patients during systemic cancer therapy
Bcl-3 deficiency regulates cancer stem cell-ness and metastatic properties in pancreatic ductal adenocarcinoma
Exocrine pancreatic cancer
The CCR5 chemokine receptor antagonist maraviroc exerts anti-neoplastic activity in pancreatic cancer cells, which may be a novel strategy for treating metastatic pancreatic cancer
New Advances in the Treatment of Metastatic Pancreatic Cancer
Targeting lAPs in pancreatic cancer therapy
The discovery of genes that exhibit strong effects on metastatic pancreatic cancer
Pancreatic cancer
Pancreatic cancer
Macrophages direct cancer cells through a LOXL2-mediated metastatic cascade in pancreatic ductal adenocarcinoma
Risk Evaluation of EMT and Inflammation in Metastatic Pancreatic Cancer Cells Following Plasma Treatment
Clinical application of liquid biopsy in targeted therapy of metastatic colorectal cancer
Implementing remote patient monitoring for patients during systemic cancer therapy
Bcl-3 deficiency regulates cancer stem cell-ness and metastatic properties in pancreatic ductal adenocarcinoma
Exocrine pancreatic cancer
The CCR5 chemokine receptor antagonist maraviroc exerts anti-neoplastic activity in pancreatic cancer cells, which may be a novel strategy for treating metastatic pancreatic cancer
New Advances in the Treatment of Metastatic Pancreatic Cancer
Targeting lAPs in pancreatic cancer therapy
The discovery of genes that exhibit strong effects on metastatic pancreatic cancer
Pancreatic cancer
Pancreatic cancer
Macrophages direct cancer cells through a LOXL2-mediated metastatic cascade in pancreatic ductal adenocarcinoma
Risk Evaluation of EMT and Inflammation in Metastatic Pancreatic Cancer Cells Following Plasma Treatment
Clinical application of liquid biopsy in targeted therapy of metastatic colorectal cancer
Implementing remote patient monitoring for patients during systemic cancer therapy
Bcl-3 deficiency regulates cancer stem cell-ness and metastatic properties in pancreatic ductal adenocarcinoma
Exocrine pancreatic cancer